IL117997A0 - Neuropeptide Y1 specific ligands - Google Patents
Neuropeptide Y1 specific ligandsInfo
- Publication number
- IL117997A0 IL117997A0 IL11799796A IL11799796A IL117997A0 IL 117997 A0 IL117997 A0 IL 117997A0 IL 11799796 A IL11799796 A IL 11799796A IL 11799796 A IL11799796 A IL 11799796A IL 117997 A0 IL117997 A0 IL 117997A0
- Authority
- IL
- Israel
- Prior art keywords
- neuropeptide
- specific ligands
- ligands
- specific
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47838395A | 1995-06-07 | 1995-06-07 | |
US48497495A | 1995-06-07 | 1995-06-07 | |
PCT/US1995/014472 WO1996014307A1 (en) | 1994-11-07 | 1995-11-07 | Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
IL117997A0 true IL117997A0 (en) | 1996-10-31 |
Family
ID=27045885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11799796A IL117997A0 (en) | 1995-06-07 | 1996-04-22 | Neuropeptide Y1 specific ligands |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0833823A1 (en) |
JP (1) | JPH10507203A (en) |
AU (1) | AU5578796A (en) |
BR (1) | BR9609334A (en) |
CA (1) | CA2220958A1 (en) |
CO (1) | CO4700426A1 (en) |
IL (1) | IL117997A0 (en) |
MA (1) | MA23860A1 (en) |
PE (1) | PE34297A1 (en) |
TR (1) | TR199600382A2 (en) |
WO (1) | WO1996040660A1 (en) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE239002T1 (en) * | 1996-07-23 | 2003-05-15 | Neurogen Corp | SOME AMIDO-AND AMINO-SUBSTITUTED BENZYLAMINE DERIVATIVES: A NEW CLASS OF NEUROPEPTIDE Y1 SPECIFIC LIGANDS |
ATE230403T1 (en) * | 1996-07-23 | 2003-01-15 | Neurogen Corp | SOME AMIDO- AND AMMO-SUBSTITUTED BENZYLAMINE DERIVATIVES: A NEW CLASS OF NEUROPEPTIDE Y1 SPECIFIC LIGANDS |
CA2260982A1 (en) * | 1996-07-23 | 1998-01-29 | Neurogen Corporation | Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
EP0927166A1 (en) * | 1997-02-14 | 1999-07-07 | Bayer Corporation | Amides as npy5 receptor antagonists |
WO1998035957A1 (en) * | 1997-02-14 | 1998-08-20 | Bayer Corporation | Amide derivatives as selective neuropeptide y receptor antagonists |
US6245817B1 (en) | 1997-02-14 | 2001-06-12 | Bayer Corporation | NPY5 receptor antagonists and methods for using same |
US6048900A (en) * | 1998-02-13 | 2000-04-11 | Bayer Corporation | Amide derivatives and methods for using the same as selective neuropeptide Y receptor antagonists |
US6420130B1 (en) | 1998-12-14 | 2002-07-16 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome P450 activity |
CA2352631A1 (en) * | 1998-12-14 | 2000-06-22 | Aurora Biosciences Corporation | Optical molecular sensors for cytochrome p450 activity |
TW200307539A (en) * | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
WO2004098591A2 (en) | 2003-05-05 | 2004-11-18 | Probiodrug Ag | Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
EP1680120A2 (en) | 2003-11-03 | 2006-07-19 | Probiodrug AG | Combinations useful for the treatment of neuronal disorders |
CN1918131B (en) | 2004-02-05 | 2011-05-04 | 前体生物药物股份公司 | Novel inhibitors of glutaminyl cyclase |
US7674811B2 (en) | 2006-03-14 | 2010-03-09 | Ranbaxy Laboratories Limited | 5-lipoxygenase inhibitors |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
SI2091948T1 (en) | 2006-11-30 | 2012-07-31 | Probiodrug Ag | Novel inhibitors of glutaminyl cyclase |
EP2481408A3 (en) | 2007-03-01 | 2013-01-09 | Probiodrug AG | New use of glutaminyl cyclase inhibitors |
DK2142514T3 (en) | 2007-04-18 | 2015-03-23 | Probiodrug Ag | Thiourea derivatives as glutaminyl cyclase inhibitors |
AU2010294214B2 (en) | 2009-09-11 | 2015-05-07 | Vivoryon Therapeutics N.V. | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
JP6026284B2 (en) | 2010-03-03 | 2016-11-16 | プロビオドルグ エージー | Inhibitors of glutaminyl cyclase |
AU2011226074B2 (en) | 2010-03-10 | 2015-01-22 | Vivoryon Therapeutics N.V. | Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5) |
EP2560953B1 (en) | 2010-04-21 | 2016-01-06 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
JP6050264B2 (en) | 2011-03-16 | 2016-12-21 | プロビオドルグ エージー | Benzimidazole derivatives as inhibitors of glutaminyl cyclase |
PL3461819T3 (en) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4845221A (en) * | 1988-04-15 | 1989-07-04 | American Home Products Corporation | Serotonergic substituted piperazinyl tetralins |
IE65362B1 (en) * | 1989-04-22 | 1995-10-18 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1996
- 1996-04-22 IL IL11799796A patent/IL117997A0/en unknown
- 1996-04-26 CA CA002220958A patent/CA2220958A1/en not_active Abandoned
- 1996-04-26 AU AU55787/96A patent/AU5578796A/en not_active Abandoned
- 1996-04-26 EP EP96913198A patent/EP0833823A1/en not_active Withdrawn
- 1996-04-26 JP JP9500490A patent/JPH10507203A/en active Pending
- 1996-04-26 BR BR9609334A patent/BR9609334A/en not_active Application Discontinuation
- 1996-04-26 WO PCT/US1996/005843 patent/WO1996040660A1/en not_active Application Discontinuation
- 1996-05-08 CO CO96022963A patent/CO4700426A1/en unknown
- 1996-05-08 PE PE1996000325A patent/PE34297A1/en not_active Application Discontinuation
- 1996-05-08 MA MA24226A patent/MA23860A1/en unknown
- 1996-05-10 TR TR96/00382A patent/TR199600382A2/en unknown
Also Published As
Publication number | Publication date |
---|---|
TR199600382A2 (en) | 1996-12-21 |
MA23860A1 (en) | 1996-12-31 |
WO1996040660A1 (en) | 1996-12-19 |
BR9609334A (en) | 1999-05-25 |
MX9709980A (en) | 1998-03-29 |
PE34297A1 (en) | 1997-09-24 |
JPH10507203A (en) | 1998-07-14 |
EP0833823A1 (en) | 1998-04-08 |
CA2220958A1 (en) | 1996-12-19 |
CO4700426A1 (en) | 1998-12-29 |
AU5578796A (en) | 1996-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL117997A0 (en) | Neuropeptide Y1 specific ligands | |
BR9509610A (en) | Y1-specific neuropeptide ligands | |
EP0731121A3 (en) | Aminomodified urethane-acrylates | |
IL122296A0 (en) | Quinolizinone type compounds | |
GB9508810D0 (en) | Compounds | |
GB9500691D0 (en) | Compounds | |
GB9504910D0 (en) | Compounds | |
GB9512129D0 (en) | Compounds | |
GB9504948D0 (en) | Compounds | |
GB9502540D0 (en) | Compounds | |
ZA963175B (en) | Neuropeptide Y1 specific ligands. | |
GB9509434D0 (en) | Compounds | |
GB9510180D0 (en) | Compounds | |
GB9502783D0 (en) | Compounds | |
GB9502782D0 (en) | Compounds | |
GB9509816D0 (en) | Compounds | |
GB9501581D0 (en) | Compounds | |
GB9501471D0 (en) | Compounds | |
GB9501357D0 (en) | Compounds | |
GB9510464D0 (en) | Compounds | |
GB9500688D0 (en) | Compounds | |
GB9502983D0 (en) | Compounds | |
GB9503211D0 (en) | Compounds | |
GB9504190D0 (en) | Compounds | |
GB9502784D0 (en) | Compounds |